Company Description

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong.

The company focuses on advancing human health and longevity through science-backed products under the IM8 brand.

It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories.

The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Prenetics Global Limited

Country	Hong Kong
Founded	2014
Industry	Diagnostics & Research
Sector	Healthcare
Employees	98
CEO	Sheng Wu Yeung

Contact Details

Address: Unit 703-706, K11 Atelier King’s Road, 728 King’s Road Quarry Bay Hong Kong
Phone	852 2210 9588
Website	prenetics.com

Stock Details

Ticker Symbol	PRE
Exchange	NASDAQ
Share Class	Class A Shares
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001876431
CUSIP Number	G72245106
ISIN Number	KYG722451229
SIC Code	3826

Key Executives

Name	Position
Samantha Kwok	Chief of Staff to Group Chief Executive Officer and Vice President of People & Operations
Sheng Wu Yeung	Co-Founder, Chairperson and Chief Executive Officer
Brian J. Rosin	Chief Financial Officer
Dr. Senthil Kumar Sundaram M.D.	Chief Clinical Officer
David Eric Vanderveen	President of Americas
Dr. James DiNicolantonio	Chief Nutrition Officer, Member of Scientific and Medical Advisory Board

Latest SEC Filings

Date	Type	Title
Jun 10, 2026	6-K	Report of foreign issuer
Jun 4, 2026	6-K	Report of foreign issuer
May 20, 2026	6-K	Report of foreign issuer
May 14, 2026	6-K	Report of foreign issuer
May 14, 2026	6-K	Report of foreign issuer
May 7, 2026	6-K	Report of foreign issuer
May 4, 2026	6-K	Report of foreign issuer
Apr 30, 2026	20-F	Annual and transition report of foreign private issuers
Apr 22, 2026	SCHEDULE 13G/A	Filing
Apr 2, 2026	6-K	Report of foreign issuer

View All SEC Filings